Serge Rivest
- Formation
- à venir
Aucune offre active
Autres opportunités de carrière
- Axe principal
- Neurosciences
- Adresse
- 2705, boulevard Laurier, T-2-50
Québec (Québec)
CANADA G1V 4G2 - Téléphone
- +1 418-525-4444, poste 42296
- Télécopieur
- +1 418-654-2298
- Courriel
- Serge.Rivest@crchuq.ulaval.ca
Projet(s) de recherche reconnu(s) par l'Université Laval
Autre(s) projet(s) de recherche actif(s)
Aucun projet de recherche à afficher
Publications récentes (voir toutes les publications de ce chercheur)
Lampron A, Elali A, Rivest S. Innate Immunity in the CNS: Redefining the Relationship between the CNS and Its Environment. Neuron,
2013. 78: 214-32
Pimentel-Coelho PM, Michaud JP, Rivest S. Effects of mild chronic cerebral hypoperfusion and early amyloid pathology on spatial learning and the cellular innate immune response in mice. Neurobiology of aging,
2013. 34: 679-93
Michaud JP, Halle M, Lampron A, Theriault P, Prefontaine P, Filali M, Tribout-Jover P, Lanteigne AM, Jodoin R, Cluff C, Brichard V, Palmantier R, Pilorget A, Larocque D, Rivest S. Toll-like receptor 4 stimulation with the detoxified ligand monophosphoryl lipid A improves Alzheimer's disease-related pathology. Proceedings of the National Academy of Sciences of the United States of America,
2013. 110: 1941-6
Elali A, Rivest S. The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer's disease. Frontiers in physiology,
2013. 4: 45
Lau LW, Keough MB, Haylock-Jacobs S, Cua R, Doring A, Sloka S, Stirling DP, Rivest S, Yong VW. Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Annals of neurology,
2012. 72: 419-32
Naert G, Rivest S. Age-related changes in synaptic markers and monocyte subsets link the cognitive decline of APP(Swe)/PS1 mice. Frontiers in cellular neuroscience,
2012. 6: 51
Bellavance MA, Rivest S. The neuroendocrine control of the innate immune system in health and brain diseases. Immunological reviews,
2012. 248: 36-55
Boivin N, Menasria R, Gosselin D, Rivest S, Boivin G. Impact of deficiency in CCR2 and CX3CR1 receptors on monocytes trafficking in herpes simplex virus encephalitis. The Journal of general virology,
2012. 93: 1294-304
Naert G, Rivest S. Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. Molecular medicine (Cambridge, Mass.)
,
2012. 18: 297-313
Michaud JP, Richard KL, Rivest S. Hematopoietic MyD88-adaptor protein acts as a natural defense mechanism for cognitive deficits in Alzheimer's disease. Stem cell reviews,
2012. 8: 898-904
